Leandri R, Buonocore S, Power K
Animals (Basel). 2025; 15(2).
PMID: 39858264
PMC: 11758335.
DOI: 10.3390/ani15020264.
Comita S, Falco P, Mezzanotte M, Vujic Spasic M, Roetto A
Int J Mol Sci. 2024; 25(17).
PMID: 39273097
PMC: 11395440.
DOI: 10.3390/ijms25179142.
Olynyk J, Grainger R, Currie H, Ramm L, Ramm G
Sci Rep. 2023; 13(1):7775.
PMID: 37179448
PMC: 10183001.
DOI: 10.1038/s41598-023-35028-4.
Silvestri L, Pettinato M, Furiosi V, Bavuso Volpe L, Nai A, Pagani A
Int J Mol Sci. 2023; 24(4).
PMID: 36835406
PMC: 9961779.
DOI: 10.3390/ijms24043995.
Kouroumalis E, Tsomidis I, Voumvouraki A
World J Gastroenterol. 2023; 29(4):616-655.
PMID: 36742167
PMC: 9896614.
DOI: 10.3748/wjg.v29.i4.616.
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis.
Handa S, Ginzburg Y, Hoffman R, Kremyanskaya M
Curr Opin Hematol. 2023; 30(2):45-52.
PMID: 36728649
PMC: 9908837.
DOI: 10.1097/MOH.0000000000000747.
Transferrin receptor 1: keeper of HFE.
Parrow N, Fleming R
Blood. 2023; 141(4):332-333.
PMID: 36701171
PMC: 9936298.
DOI: 10.1182/blood.2022018740.
Effects of Excess Iron on the Retina: Insights From Clinical Cases and Animal Models of Iron Disorders.
Shahandeh A, Bui B, Finkelstein D, Nguyen C
Front Neurosci. 2022; 15:794809.
PMID: 35185447
PMC: 8851357.
DOI: 10.3389/fnins.2021.794809.
The hypoferremic response to acute inflammation is maintained in thalassemia mice even under parenteral iron loading.
Sanyear C, Chiawtada B, Butthep P, Svasti S, Fucharoen S, Masaratana P
PeerJ. 2021; 9:e11367.
PMID: 33987030
PMC: 8092106.
DOI: 10.7717/peerj.11367.
Inflaming the Brain with Iron.
Urrutia P, Borquez D, Nunez M
Antioxidants (Basel). 2021; 10(1).
PMID: 33419006
PMC: 7825317.
DOI: 10.3390/antiox10010061.
Higher iron stores and the HFE 187C>G variant delay onset of peripheral neuropathy during combination antiretroviral therapy.
Kallianpur A, Wen W, Erwin A, Clifford D, Hulgan T, Robbins G
PLoS One. 2020; 15(10):e0239758.
PMID: 33057367
PMC: 7561201.
DOI: 10.1371/journal.pone.0239758.
[Progress on epigenetic regulation of iron homeostasis].
Duan L, Yin X, Meng H, Fang X, Min J, Wang F
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020; 49(1):58-70.
PMID: 32621410
PMC: 8800797.
DOI: 10.3785/j.issn.1008-9292.2020.02.25.
Bone morphogenic proteins in iron homeostasis.
Xiao X, Alfaro-Magallanes V, Babitt J
Bone. 2020; 138:115495.
PMID: 32585319
PMC: 7453787.
DOI: 10.1016/j.bone.2020.115495.
HFE Related Hemochromatosis: Uncovering the Inextricable Link between Iron Homeostasis and the Immunological System.
Porto G, Cruz E, Teles M, de Sousa M
Pharmaceuticals (Basel). 2019; 12(3).
PMID: 31443397
PMC: 6789554.
DOI: 10.3390/ph12030122.
Polycythemia in Patients With Hereditary Hemochromatosis: Real or Myth?.
Asif S, Begemann M, Raza S
J Clin Med Res. 2019; 11(6):422-427.
PMID: 31143309
PMC: 6522237.
DOI: 10.14740/jocmr3816.
Hepcidin-ferroportin axis in health and disease.
Ginzburg Y
Vitam Horm. 2019; 110:17-45.
PMID: 30798811
PMC: 7730607.
DOI: 10.1016/bs.vh.2019.01.002.
Iron as a Therapeutic Target in -Related Hemochromatosis: Usual and Novel Aspects.
Loreal O, Cavey T, Robin F, Kenawi M, Guggenbuhl P, Brissot P
Pharmaceuticals (Basel). 2018; 11(4).
PMID: 30486249
PMC: 6315470.
DOI: 10.3390/ph11040131.
The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value.
Roetto A, Mezzanotte M, Pellegrino R
Pharmaceuticals (Basel). 2018; 11(4).
PMID: 30360575
PMC: 6316356.
DOI: 10.3390/ph11040115.
Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry.
Wessling-Resnick M
Annu Rev Nutr. 2018; 38:431-458.
PMID: 29852086
PMC: 6743070.
DOI: 10.1146/annurev-nutr-082117-051749.
DNA methylation of hepatic iron sensing genes and the regulation of hepcidin expression.
Sharp P, Clarkson R, Hussain A, Weeks R, Morison I
PLoS One. 2018; 13(5):e0197863.
PMID: 29771984
PMC: 5957407.
DOI: 10.1371/journal.pone.0197863.